[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
February 18, 2004

Expanded Screening of Newborns for Genetic Disorders

Author Affiliations

Letters Section Editor: Stephen J. Lurie, MD, PhD, Senior Editor.

JAMA. 2004;291(7):820-821. doi:10.1001/jama.291.7.820-c

To the Editor: Dr Holtzman, in his Editorial1 accompanying our study of expanded newborn screening for biochemical genetic disorders,2 stated that adoption of new screening technology was brought about by pressure from medico-legal proceedings initiated by parents. He did not mention, however, the strong and dedicated advocacy from metabolic and genetic physicians, individually and through organizations such as the Society of Inherited Metabolic disorders, who recognized the potential benefit to patients and their families.